Close

Digital Health Summer Summit and BIO International Convention to Convene Under One Roof to Ignite the Digital Health Tipping Point

Apr 11 2016
Both conferences to be held in San Francisco June 6 - 9, 2016 bringing leaders in biotech, pharma and technology together  

BIO Announces GreenTech Investor Sessions for 2016 BIO World Congress on Industrial Biotechnology

Apr 7 2016
The Biotechnology Innovation Organization (BIO) has announced the elite group of emerging industrial biotechnology companies that will be presenting at the GreenTech Investor Sessions during BIO’s 13th Annual World Congress on Industrial Biotechnology.

BIO Praises Advancement of Senate Biomedical Innovation Legislation

Apr 6 2016
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding today’s Senate HELP Committee mark-up of legislation as part of the Senate biomedical innovation initiative...

Biofuel Trade Associations Ask Congressional Leaders to Extend Advanced Biofuel Incentives

Apr 5 2016
Today, six biofuel trade associations sent a letter to House and Senate leaders asking Congress for a multiyear extension of advanced biofuel tax credits. 

BIO Announces IAR – The French Bioeconomy Cluster as a Key Supporting Organization of the 2016 BIO World Congress on Industrial Biotechnology

Apr 4 2016
The Biotechnology Innovation Organization (BIO) is pleased to announce that Europe’s largest cluster of bioeconomy companies, IAR, will be a top supporting organization of BIO’s 13th Annual World Congress on Industrial Biotechnology. 

NexSteppe Inc. CEO Selected to Receive the 2016 BIO Rosalind Franklin Award

Mar 31 2016
The Biotechnology Innovation Organization (BIO) announced today that President and CEO of NexSteppe, Anna Rath, has been selected by a committee of her peers to be the recipient of the 2016 BIO Rosalind Franklin Award. 

BIO Statement on American College of Physicians’ Prescription Drug Plan

Mar 30 2016
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement today regarding the American College of Physicians’ policy paper on prescription drugs.

2016 BIO World Congress on Industrial Biotechnology Exhibition Hall to Feature NSF Small Business Innovation Research Companies

Mar 28 2016
The Biotechnology Innovation Organization (BIO) in partnership with the National Science Foundation (NSF) will feature Small Business Innovation Research (SBIR) funded early-stage industrial biotech companies at BIO’s 13thAnnual World Congress on Industrial Biotechnology.  

BIO Announces Plenary Session Speakers for the 2016 World Congress on Industrial Biotechnology

Mar 23 2016
The Biotechnology Innovation Organization (BIO) announces that executives, thought leaders, and government  officials will discuss applications in space, biofuels, and the renewable chemical landscape during plenary programs at BIO’s 13th Annual World Congress on Industrial Biotechnology

BIO Statement on FDA and NIH Workforce Authorities Modernization Act

Mar 17 2016
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the introduction today by Senators Alexander and Murray of the FDA and NIH Workforce Authorities Modernization Act: